MEDMARK PHARMA GMBH has a total of 18 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EXODOS LIFE SCIENCES LTD PARTNERSHIP, ITF RES PHARMA S L U and APPLIED MED RES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 1 | |
#5 | Finland | 1 | |
#6 | Hungary | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nordstroem Rabbe | 8 |
#2 | Wecker Eberhard | 6 |
#3 | Nagler Apollonia | 6 |
#4 | Schimpl Anneliese | 5 |
#5 | Wiebecke Dieter | 3 |
#6 | Schimpl Anneliese Prof Dr Phil | 1 |
#7 | Wecker Eberhard Prof Dr Med Dr | 1 |
#8 | Schimpl Annelise | 1 |
#9 | Wecker Eberhard Prof Dr Med | 1 |
#10 | Schiml Anneliese Prof Dr Phil | 1 |
Publication | Filing date | Title |
---|---|---|
DE19829448A1 | 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholine (ET180CH3) for the treatment of human breast cancer | |
DE19822509A1 | Use of edelfosin for treatment of brain tumors, especially by oral administration | |
DE4000084A1 | INTRAVENOES APPLICABLE PHARMACEUTICAL PREPARATION OF ET18-OCH (DOWN ARROW) 3 (DOWN ARROW) | |
DE3943000A1 | Phospholipid analogues prodn. - with immunostimulant and antitumour activity, starting from allyl glycidyl ether and allyl alcohol | |
DE3941009A1 | ELIMINATION OF ACTIVATED LYMPHOCYTES | |
DE3935580A1 | Use of an active pharmaceutical ingredient for the treatment of HIV infections |